製薬受託製造の世界市場2020-2030

【英語タイトル】Pharmaceutical Contract Manufacturing Market Report 2020-2030

visiongainが出版した調査資料(VGA20DE023)・商品コード:VGA20DE023
・発行会社(調査会社):visiongain
・発行日:2020年9月
・ページ数:543
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用)USD5,850 ⇒換算¥608,400見積依頼/購入/質問フォーム
Global Site License(法人閲覧用)USD9,099 ⇒換算¥946,296見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Discover sales predictions for the world market and submarkets
Product Category
• Pharmaceutical Product Manufacturing
• Biological Product Manufacturing
Drug Type
• API Manufacturing
• FDF Manufacturing
API
• Small Molecule
• Large Molecule
• High Potency API (HPAPI)
FDF
• Solid Dose Formulation
• Liquid Dose Formulation
• Injectable Dose Formulation
• Other FDFs
By End-User
• Big Pharma
• Small & Mid-size Pharma
• Generic Pharmaceutical Companies
• Other End-Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East and Africa
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Egypt
• Rest of Middle East and Africa
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.

【レポートの目次】

1 Report Overview
1.1 Scope of Report
1.2 Why You Should Buy This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.7 Market Evaluation & Forecasting Methodology
1.8 COIVD-19 Impact Recovery Pattern Analysis
1.8.1 V-Shaped Recovery
1.8.2 U-Shaped Recovery
1.8.3 W-Shaped Recovery
1.8.4 L-Shaped Recovery
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2 Executive Summary
2.1 Pharmaceutical Product Manufacturing Segment is Expected to Maintain its Dominance in the Global Market
2.2 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market
3 Market Dynamics
3.1 Factors Affecting Growth
3.1.1 Product and Process Innovation
3.1.2 Continuing Focus on Productivity
3.1.3 Cost Savings
3.1.4 Risk Management
3.1.5 Stringent Regulations
3.1.6 Patent Expirations
3.1.7 Decreasing Research and Development Success Rates
3.2 Market Drivers
3.2.1 Increasing Demand of Biosimilars
3.2.2 Increased Focus on Orphan and Specialty Drugs
3.2.3 Generics: A Driver or Restraint?
3.2.4 Increasing Demand for Formulation Development Services
3.2.5 Bio/Pharmaceutical Manufacturers’ Move Toward Strategic Collaboration With Drug Delivery Technology Companies
3.3 Opportunities in the Global Market
3.3.1 Lack of Manufacturing and Packaging Capabilities
3.3.2 Pharma Companies Will Continue To Look For Ways To Cut Drug Costs
3.3.3 Need for New Drug Delivery Technologies
3.3.4 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs
3.4 Growth Restrain
3.4.1 Backwards Integration for Generics Manufacturers
3.4.2 The US Generic Drug User Fee Act and API Manufacturing
3.5 Challenges in Contract Manufacturing
3.5.1 Challenges in Assessing the Market: Supply versus Demand
3.6 SWOT Analysis
3.7 Porter’s Five Forces Analysis
3.7.1 What are Porter Five (5) Forces
3.7.2 Threat of New Entrants (Low to Moderate)
3.7.3 Rivalry Among the Existing Players (High)
3.7.4 Bargaining Power of Suppliers (Low)
3.7.5 Threats from Substitute Products (Low to Moderate)
3.7.6 Bargaining Power of Buyers (High)
4 Global Pharmaceutical Contract Manufacturing Market
4.1 Industry Structure Overview
4.1.1 Pharmaceutical Landscape
4.1.2 Objectives of Outsourcing
4.1.3 Contract Manufacturing Types
4.1.4 Suitable Services Provider
4.1.5 Benefits of Outsourcing
4.1.6 Drawbacks of Outsourcing
4.1.7 Outsourcing
4.1.8 Core Capabilities of Contract Manufacturing Organization
4.1.9 Services Offered by Contract Manufacturing Organizations
5 Global Pharmaceutical Contract Manufacturing Market
5.1 Overview
5.1.1 Analysis of Market Status Before COVID-19
5.1.2 Analysis of Market V-Shaped Recovery Pattern
5.1.3 Analysis of Market W-Shaped Recovery Pattern
5.1.4 Analysis of Market U-Shaped Recovery Pattern
5.1.5 Analysis of Market L-Shaped Recovery Pattern
5.2 Regional Market Overview
5.2.1 Analysis of Market Status Before COVID-19
5.2.2 Analysis of Market V-Shaped Recovery Pattern
5.2.3 Analysis of Market W-Shaped Recovery Pattern
5.2.4 Analysis of Market U-Shaped Recovery Pattern
5.2.5 Analysis of Market L-Shaped Recovery Pattern
5.3 Product Category Market Overview
5.3.1 Analysis of Market Status Before COVID-19
5.3.2 Analysis of Market V-Shaped Recovery Pattern
5.3.3 Analysis of Market W-Shaped Recovery Pattern
5.3.4 Analysis of Market U-Shaped Recovery Pattern
5.3.5 Analysis of Market L-Shaped Recovery Pattern
5.4 Drug Type Market Overview
5.4.1 Analysis of Market Status Before COVID-19
5.4.2 Analysis of Market V-Shaped Recovery Pattern
5.4.3 Analysis of Market W-Shaped Recovery Pattern
5.4.4 Analysis of Market U-Shaped Recovery Pattern
5.4.5 Analysis of Market L-Shaped Recovery Pattern
5.5 API Contract Manufacturing Market Overview
5.5.1 Analysis of Market Status Before COVID-19
5.5.2 Analysis of Market V-Shaped Recovery Pattern
5.5.3 Analysis of Market W-Shaped Recovery Pattern
5.5.4 Analysis of Market U-Shaped Recovery Pattern
5.5.5 Analysis of Market L-Shaped Recovery Pattern
5.6 FDF Contract Manufacturing Market Overview
5.6.1 Analysis of Market Status Before COVID-19
5.6.2 Analysis of Market V-Shaped Recovery Pattern
5.6.3 Analysis of Market W-Shaped Recovery Pattern
5.6.4 Analysis of Market U-Shaped Recovery Pattern
5.6.5 Analysis of Market L-Shaped Recovery Pattern
5.7 End-User Market Overview
5.7.1 Analysis of Market Status Before COVID-19
5.7.2 Analysis of Market V-Shaped Recovery Pattern
5.7.3 Analysis of Market W-Shaped Recovery Pattern
5.7.4 Analysis of Market U-Shaped Recovery Pattern
5.7.5 Analysis of Market L-Shaped Recovery Pattern
6 Global Market Analysis by Product Category
6.1 Pharmaceutical Product Manufacturing Market Analysis by Region
6.1.1 Market Overview
6.1.2 Analysis of Market Status Before COVID-19
6.1.3 Analysis of Market V-Shaped Recovery Pattern
6.1.4 Analysis of Market W-Shaped Recovery Pattern
6.1.5 Analysis of Market U-Shaped Recovery Pattern
6.1.6 Analysis of Market L-Shaped Recovery Pattern
6.2 Biological Product Manufacturing Market Analysis by Region
6.2.1 Market Overview
6.2.2 Analysis of Market Status Before COVID-19
6.2.3 Analysis of Market V-Shaped Recovery Pattern
6.2.4 Analysis of Market W-Shaped Recovery Pattern
6.2.5 Analysis of Market U-Shaped Recovery Pattern
6.2.6 Analysis of Market L-Shaped Recovery Pattern
7 Global Market Analysis by Drug Type
7.1 Active Pharmaceutical Ingredient Manufacturing Market Analysis by Region
7.1.1 Market Overview
7.1.2 Analysis of Market Status Before COVID-19
7.1.3 Analysis of Market V-Shaped Recovery Pattern
7.1.4 Analysis of Market W-Shaped Recovery Pattern
7.1.5 Analysis of Market U-Shaped Recovery Pattern
7.1.6 Analysis of Market L-Shaped Recovery Pattern
7.2 Finished Dosage Form Products Manufacturing Market Analysis by Region
7.2.1 Analysis of Market Status Before COVID-19
7.2.2 Analysis of Market V-Shaped Recovery Pattern
7.2.3 Analysis of Market W-Shaped Recovery Pattern
7.2.4 Analysis of Market U-Shaped Recovery Pattern
7.2.5 Analysis of Market L-Shaped Recovery Pattern
8 Global Market Analysis by Active Pharmaceutical Ingredients Contract Manufacturing
8.1 API Small Molecule Manufacturing Market Analysis by Region
8.1.1 Analysis of Market Status Before COVID-19
8.1.2 Analysis of Market V-Shaped Recovery Pattern
8.1.3 Analysis of Market W-Shaped Recovery Pattern
8.1.4 Analysis of Market U-Shaped Recovery Pattern
8.1.5 Analysis of Market L-Shaped Recovery Pattern
8.2 API Large Molecule Manufacturing Market Analysis by Region
8.2.1 Analysis of Market Status Before COVID-19
8.2.2 Analysis of Market V-Shaped Recovery Pattern
8.2.3 Analysis of Market W-Shaped Recovery Pattern
8.2.4 Analysis of Market U-Shaped Recovery Pattern
8.2.5 Analysis of Market L-Shaped Recovery Pattern
8.3 High Potency API (HPAPI) Manufacturing Market Analysis by Region
8.3.1 Challenges and Opportunities in High Containment Manufacturing
8.3.2 Analysis of Market Status Before COVID-19
8.3.3 Analysis of Market V-Shaped Recovery Pattern
8.3.4 Analysis of Market W-Shaped Recovery Pattern
8.3.5 Analysis of Market U-Shaped Recovery Pattern
8.3.6 Analysis of Market L-Shaped Recovery Pattern
9 Global Market Analysis by Finished Dosage Form Contract Manufacturing
9.1 Solid Dose Formulation Manufacturing Market Analysis by Region
9.1.1 Market Overview
9.1.2 Analysis of Market Status Before COVID-19
9.1.3 Analysis of Market V-Shaped Recovery Pattern
9.1.4 Analysis of Market W-Shaped Recovery Pattern
9.1.5 Analysis of Market U-Shaped Recovery Pattern
9.1.6 Analysis of Market L-Shaped Recovery Pattern
9.2 Liquid Dose Formulation Manufacturing Market Analysis by Region
9.2.1 Market Overview
9.2.2 Nonsterile Formulations
9.2.3 Analysis of Market Status Before COVID-19
9.2.4 Analysis of Market V-Shaped Recovery Pattern
9.2.5 Analysis of Market W-Shaped Recovery Pattern
9.2.6 Analysis of Market U-Shaped Recovery Pattern
9.2.7 Analysis of Market L-Shaped Recovery Pattern
9.3 Injectable Dose Formulation Manufacturing Market Analysis by Region
9.3.1 Sterile Formulations
9.3.2 Analysis of Market Status Before COVID-19
9.3.3 Analysis of Market V-Shaped Recovery Pattern
9.3.4 Analysis of Market W-Shaped Recovery Pattern
9.3.5 Analysis of Market U-Shaped Recovery Pattern
9.3.6 Analysis of Market L-Shaped Recovery Pattern
9.4 Other FDF Dose Formulation Manufacturing Market Analysis by Region
9.4.1 Semi-Solid Dosage Forms
9.4.2 Advanced Drug Delivery Products
9.4.3 Market Overview
9.4.4 Analysis of Market Status Before COVID-19
9.4.5 Analysis of Market V-Shaped Recovery Pattern
9.4.6 Analysis of Market W-Shaped Recovery Pattern
9.4.7 Analysis of Market U-Shaped Recovery Pattern
9.4.8 Analysis of Market L-Shaped Recovery Pattern
10 Global Market Analysis by End-User
10.1 Big Pharmaceutical Contract Manufacturing Market Analysis by Region
10.1.1 Analysis of Market Status Before COVID-19
10.1.2 Analysis of Market V-Shaped Recovery Pattern
10.1.3 Analysis of Market W-Shaped Recovery Pattern
10.1.4 Analysis of Market U-Shaped Recovery Pattern
10.1.5 Analysis of Market L-Shaped Recovery Pattern
10.2 Small & Mid-size Pharmaceutical Contract Manufacturing Market Analysis by Region
10.2.1 Analysis of Market Status Before COVID-19
10.2.2 Analysis of Market V-Shaped Recovery Pattern
10.2.3 Analysis of Market W-Shaped Recovery Pattern
10.2.4 Analysis of Market U-Shaped Recovery Pattern
10.2.5 Analysis of Market L-Shaped Recovery Pattern
10.3 Generic Pharmaceutical Companies Contract Manufacturing Market Analysis by Region
10.3.1 Analysis of Market Status Before COVID-19
10.3.2 Analysis of Market V-Shaped Recovery Pattern
10.3.3 Analysis of Market W-Shaped Recovery Pattern
10.3.4 Analysis of Market U-Shaped Recovery Pattern
10.3.5 Analysis of Market L-Shaped Recovery Pattern
10.4 Other End-User Contract Manufacturing Market Analysis by Region
10.4.1 Analysis of Market Status Before COVID-19
10.4.2 Analysis of Market V-Shaped Recovery Pattern
10.4.3 Analysis of Market W-Shaped Recovery Pattern
10.4.4 Analysis of Market U-Shaped Recovery Pattern
10.4.5 Analysis of Market L-Shaped Recovery Pattern
11 North America Pharmaceutical Contract Manufacturing Market Analysis
11.1 North America Market in Terms of Value
11.1.1 Analysis of Market Status Before COVID-19
11.1.2 Analysis of Market V-Shaped Recovery Pattern
11.1.3 Analysis of Market W-Shaped Recovery Pattern
11.1.4 Analysis of Market U-Shaped Recovery Pattern
11.1.5 Analysis of Market L-Shaped Recovery Pattern
11.2 US Pharmaceutical Contract Manufacturing Market Analysis
11.2.1 Pharmaceutical Manufacturing in the US: Regulatory Oversight, 2019
11.2.2 Controlling Foreign Manufacturing Sites
11.2.3 Outsourcing and US Manufacturing Regulations
11.2.4 Increased Demand for Domestic API Manufacturing?
11.2.5 Analysis of Market Status Before COVID-19
11.2.6 Analysis of Market V-Shaped Recovery Pattern
11.2.7 Analysis of Market W-Shaped Recovery Pattern
11.2.8 Analysis of Market U-Shaped Recovery Pattern
11.2.9 Analysis of Market L-Shaped Recovery Pattern
11.3 Canada Pharmaceutical Contract Manufacturing Market Analysis
11.3.1 Analysis of Market Status Before COVID-19
11.3.2 Analysis of Market V-Shaped Recovery Pattern
11.3.3 Analysis of Market W-Shaped Recovery Pattern
11.3.4 Analysis of Market U-Shaped Recovery Pattern
11.3.5 Analysis of Market L-Shaped Recovery Pattern
11.4 North America Market Analysis by Product Category
11.4.1 Analysis of Market Status Before COVID-19
11.4.2 Analysis of Market V-Shaped Recovery Pattern
11.4.3 Analysis of Market W-Shaped Recovery Pattern
11.4.4 Analysis of Market U-Shaped Recovery Pattern
11.4.5 Analysis of Market L-Shaped Recovery Pattern
11.5 North America Market Analysis by Drug Type
11.5.1 Analysis of Market Status Before COVID-19
11.5.2 Analysis of Market V-Shaped Recovery Pattern
11.5.3 Analysis of Market W-Shaped Recovery Pattern
11.5.4 Analysis of Market U-Shaped Recovery Pattern
11.5.5 Analysis of Market L-Shaped Recovery Pattern
11.6 North America Market Analysis by API Contract Manufacturing
11.6.1 Analysis of Market Status Before COVID-19
11.6.2 Analysis of Market V-Shaped Recovery Pattern
11.6.3 Analysis of Market W-Shaped Recovery Pattern
11.6.4 Analysis of Market U-Shaped Recovery Pattern
11.6.5 Analysis of Market L-Shaped Recovery Pattern
11.7 North America Market Analysis by FDF Contract Manufacturing
11.7.1 Analysis of Market Status Before COVID-19
11.7.2 Analysis of Market V-Shaped Recovery Pattern
11.7.3 Analysis of Market W-Shaped Recovery Pattern
11.7.4 Analysis of Market U-Shaped Recovery Pattern
11.7.5 Analysis of Market L-Shaped Recovery Pattern
11.8 North America Market Analysis by End-User
11.8.1 Analysis of Market Status Before COVID-19
11.8.2 Analysis of Market V-Shaped Recovery Pattern
11.8.3 Analysis of Market W-Shaped Recovery Pattern
11.8.4 Analysis of Market U-Shaped Recovery Pattern
11.8.5 Analysis of Market L-Shaped Recovery Pattern
12 Europe Pharmaceutical Contract Manufacturing Market Analysis
12.1.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing
12.1.2 Regulatory Aspects of Pharma Manufacturing in the EU
12.1.3 The European Commission Amends Annex 16
12.1.4 The Falsified Medicine Directive: Controlling API Imports
12.1.5 Biopharma Manufacturing Demand Will Rise
12.1.6 The EU Contract Manufacturing Market Forecast 2020-2030
12.2 Europe Market in Terms of Value
12.2.1 Analysis of Market Status Before COVID-19
12.2.2 Analysis of Market V-Shaped Recovery Pattern
12.2.3 Analysis of Market W-Shaped Recovery Pattern
12.2.4 Analysis of Market U-Shaped Recovery Pattern
12.2.5 Analysis of Market L-Shaped Recovery Pattern
12.3 Germany Pharmaceutical Contract Manufacturing Market Analysis
12.3.1 Germany: The Leading EU Destination for API and FDF Manufacturing
12.3.2 Demand for Contract Manufacturing in Germany
12.3.3 Analysis of Market Status Before COVID-19
12.3.4 Analysis of Market V-Shaped Recovery Pattern
12.3.5 Analysis of Market W-Shaped Recovery Pattern
12.3.6 Analysis of Market U-Shaped Recovery Pattern
12.3.7 Analysis of Market L-Shaped Recovery Pattern
12.4 France Pharmaceutical Contract Manufacturing Market Analysis
12.4.1 Analysis of Market Status Before COVID-19
12.4.2 Analysis of Market V-Shaped Recovery Pattern
12.4.3 Analysis of Market W-Shaped Recovery Pattern
12.4.4 Analysis of Market U-Shaped Recovery Pattern
12.4.5 Analysis of Market L-Shaped Recovery Pattern
12.5 UK Pharmaceutical Contract Manufacturing Market Analysis
12.5.1 Analysis of Market Status Before COVID-19
12.5.2 Analysis of Market V-Shaped Recovery Pattern
12.5.3 Analysis of Market W-Shaped Recovery Pattern
12.5.4 Analysis of Market U-Shaped Recovery Pattern
12.5.5 Analysis of Market L-Shaped Recovery Pattern
12.6 Italy Pharmaceutical Contract Manufacturing Market Analysis
12.6.1 Italy: Strong API Manufacturing Traditions
12.6.2 Revenue Forecast for the Italian Pharma Contract Manufacturing
12.6.3 Analysis of Market Status Before COVID-19
12.6.4 Analysis of Market V-Shaped Recovery Pattern
12.6.5 Analysis of Market W-Shaped Recovery Pattern
12.6.6 Analysis of Market U-Shaped Recovery Pattern
12.6.7 Analysis of Market L-Shaped Recovery Pattern
12.7 Spain Pharmaceutical Contract Manufacturing Market Analysis
12.7.1 Spain: How Will Demand for Manufacturing Services Grow?
12.7.2 Analysis of Market Status Before COVID-19
12.7.3 Analysis of Market V-Shaped Recovery Pattern
12.7.4 Analysis of Market W-Shaped Recovery Pattern
12.7.5 Analysis of Market U-Shaped Recovery Pattern
12.7.6 Analysis of Market L-Shaped Recovery Pattern
12.8 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis
12.8.1 Compliance with GMP in Russia
12.8.2 How Will Demand for Contract Manufacturing Grow in Russia to 2030?
12.8.3 Analysis of Market Status Before COVID-19
12.8.4 Analysis of Market V-Shaped Recovery Pattern
12.8.5 Analysis of Market W-Shaped Recovery Pattern
12.8.6 Analysis of Market U-Shaped Recovery Pattern
12.8.7 Analysis of Market L-Shaped Recovery Pattern
12.9 Europe Market Analysis by Product Category
12.9.1 Analysis of Market Status Before COVID-19
12.9.2 Analysis of Market V-Shaped Recovery Pattern
12.9.3 Analysis of Market W-Shaped Recovery Pattern
12.9.4 Analysis of Market U-Shaped Recovery Pattern
12.9.5 Analysis of Market L-Shaped Recovery Pattern
12.10 Europe Market Analysis by Drug Type
12.10.1 Analysis of Market Status Before COVID-19
12.10.2 Analysis of Market V-Shaped Recovery Pattern
12.10.3 Analysis of Market W-Shaped Recovery Pattern
12.10.4 Analysis of Market U-Shaped Recovery Pattern
12.10.5 Analysis of Market L-Shaped Recovery Pattern
12.11 Europe Market Analysis by API Contract Manufacturing
12.11.1 Analysis of Market Status Before COVID-19
12.11.2 Analysis of Market V-Shaped Recovery Pattern
12.11.3 Analysis of Market W-Shaped Recovery Pattern
12.11.4 Analysis of Market U-Shaped Recovery Pattern
12.11.5 Analysis of Market L-Shaped Recovery Pattern
12.12 Europe Market Analysis by FDF Contract Manufacturing
12.12.1 Analysis of Market Status Before COVID-19
12.12.2 Analysis of Market V-Shaped Recovery Pattern
12.12.3 Analysis of Market W-Shaped Recovery Pattern
12.12.4 Analysis of Market U-Shaped Recovery Pattern
12.12.5 Analysis of Market L-Shaped Recovery Pattern
12.13 Europe Market Analysis by End-User
12.13.1 Analysis of Market Status Before COVID-19
12.13.2 Analysis of Market V-Shaped Recovery Pattern
12.13.3 Analysis of Market W-Shaped Recovery Pattern
12.13.4 Analysis of Market U-Shaped Recovery Pattern
12.13.5 Analysis of Market L-Shaped Recovery Pattern
13 Asia-Pacific Pharmaceutical Contract Manufacturing Market Analysis
13.1.1 Demand Will Increase for Services in India and China
13.2 Asia-Pacific Market in Terms of Value
13.2.1 Analysis of Market Status Before COVID-19
13.2.2 Analysis of Market V-Shaped Recovery Pattern
13.2.3 Analysis of Market W-Shaped Recovery Pattern
13.2.4 Analysis of Market U-Shaped Recovery Pattern
13.2.5 Analysis of Market L-Shaped Recovery Pattern
13.3 Japan Pharmaceutical Contract Manufacturing Market Analysis
13.3.1 Pharmaceutical Manufacturing Regulations in Japan
13.3.2 The Pharmaceutical Affairs Law
13.3.3 Analysis of Market Status Before COVID-19
13.3.4 Analysis of Market V-Shaped Recovery Pattern
13.3.5 Analysis of Market W-Shaped Recovery Pattern
13.3.6 Analysis of Market U-Shaped Recovery Pattern
13.3.7 Analysis of Market L-Shaped Recovery Pattern
13.4 China Pharmaceutical Contract Manufacturing Market Analysis
13.4.1 Chinese Demand for Pharma Contract Manufacturing Services
13.4.2 Improved Manufacturing Regulations in China
13.4.3 Regulations for Excipients and Guidance for API Manufacturing
13.4.4 What Are the Consequences to Stricter Manufacturing Regulations in China?
13.4.5 Chinese CMOs Are Investing in Biopharma Manufacturing
13.4.6 China Pharma Contract Manufacturing Market
13.4.7 Analysis of Market Status Before COVID-19
13.4.8 Analysis of Market V-Shaped Recovery Pattern
13.4.9 Analysis of Market W-Shaped Recovery Pattern
13.4.10 Analysis of Market U-Shaped Recovery Pattern
13.4.11 Analysis of Market L-Shaped Recovery Pattern
13.5 India Pharmaceutical Contract Manufacturing Market Analysis
13.5.1 Regulatory Outlook for Indian Pharma Manufacturing
13.5.2 Stricter Quality Standards to Ensure Compliance with EU Rules
13.5.3 Domestic Manufacturing Dominates the Indian Pharma Market
13.5.4 Demand for Contract Manufacturing in India
13.5.5 Analysis of Market Status Before COVID-19
13.5.6 Analysis of Market V-Shaped Recovery Pattern
13.5.7 Analysis of Market W-Shaped Recovery Pattern
13.5.8 Analysis of Market U-Shaped Recovery Pattern
13.5.9 Analysis of Market L-Shaped Recovery Pattern
13.6 South Korea Pharmaceutical Contract Manufacturing Market Analysis
13.6.1 South Korea: Government Supported Growth
13.6.2 South Korea: Strict GMP Regulations
13.6.3 South Korea: Pharma Contract Manufacturing Market
13.6.4 Analysis of Market Status Before COVID-19
13.6.5 Analysis of Market V-Shaped Recovery Pattern
13.6.6 Analysis of Market W-Shaped Recovery Pattern
13.6.7 Analysis of Market U-Shaped Recovery Pattern
13.6.8 Analysis of Market L-Shaped Recovery Pattern
13.7 Australia Pharmaceutical Contract Manufacturing Market Analysis
13.7.1 Analysis of Market Status Before COVID-19
13.7.2 Analysis of Market V-Shaped Recovery Pattern
13.7.3 Analysis of Market W-Shaped Recovery Pattern
13.7.4 Analysis of Market U-Shaped Recovery Pattern
13.7.5 Analysis of Market L-Shaped Recovery Pattern
13.8 Rest of APAC Pharmaceutical Contract Manufacturing Market Analysis
13.8.1 Analysis of Market Status Before COVID-19
13.8.2 Analysis of Market V-Shaped Recovery Pattern
13.8.3 Analysis of Market W-Shaped Recovery Pattern
13.8.4 Analysis of Market U-Shaped Recovery Pattern
13.8.5 Analysis of Market L-Shaped Recovery Pattern
13.9 Asia-Pacific Market Analysis by Product Category
13.9.1 Analysis of Market Status Before COVID-19
13.9.2 Analysis of Market V-Shaped Recovery Pattern
13.9.3 Analysis of Market W-Shaped Recovery Pattern
13.9.4 Analysis of Market U-Shaped Recovery Pattern
13.9.5 Analysis of Market L-Shaped Recovery Pattern
13.10 Asia-Pacific Market Analysis by Drug Type
13.10.1 Analysis of Market Status Before COVID-19
13.10.2 Analysis of Market V-Shaped Recovery Pattern
13.10.3 Analysis of Market W-Shaped Recovery Pattern
13.10.4 Analysis of Market U-Shaped Recovery Pattern
13.10.5 Analysis of Market L-Shaped Recovery Pattern
13.11 Asia-Pacific Market Analysis by API Contract Manufacturing
13.11.1 Analysis of Market Status Before COVID-19
13.11.2 Analysis of Market V-Shaped Recovery Pattern
13.11.3 Analysis of Market W-Shaped Recovery Pattern
13.11.4 Analysis of Market U-Shaped Recovery Pattern
13.11.5 Analysis of Market L-Shaped Recovery Pattern
13.12 Asia-Pacific Market Analysis by FDF Contract Manufacturing
13.12.1 Analysis of Market Status Before COVID-19
13.12.2 Analysis of Market V-Shaped Recovery Pattern
13.12.3 Analysis of Market W-Shaped Recovery Pattern
13.12.4 Analysis of Market U-Shaped Recovery Pattern
13.12.5 Analysis of Market L-Shaped Recovery Pattern
13.13 Asia-Pacific Market Analysis by End-User
13.13.1 Analysis of Market Status Before COVID-19
13.13.2 Analysis of Market V-Shaped Recovery Pattern
13.13.3 Analysis of Market W-Shaped Recovery Pattern
13.13.4 Analysis of Market U-Shaped Recovery Pattern
13.13.5 Analysis of Market L-Shaped Recovery Pattern
14 Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis
14.1 Middle East & Africa Market in Terms of Value
14.1.1 Analysis of Market Status Before COVID-19
14.1.2 Analysis of Market V-Shaped Recovery Pattern
14.1.3 Analysis of Market W-Shaped Recovery Pattern
14.1.4 Analysis of Market U-Shaped Recovery Pattern
14.1.5 Analysis of Market L-Shaped Recovery Pattern
14.2 Turkey Pharmaceutical Contract Manufacturing Market Analysis
14.2.1 Turkey: Domestic Market to offer Huge Growth Opportunities
14.2.2 Turkey: An Important Hub for Global Pharma Companies
14.2.3 Drug Approvals Delaying Growth of the Turkey Pharma Market
14.2.4 Analysis of Market Status Before COVID-19
14.2.5 Analysis of Market V-Shaped Recovery Pattern
14.2.6 Analysis of Market W-Shaped Recovery Pattern
14.2.7 Analysis of Market U-Shaped Recovery Pattern
14.2.8 Analysis of Market L-Shaped Recovery Pattern
14.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Analysis
14.3.1 Analysis of Market Status Before COVID-19
14.3.2 Analysis of Market V-Shaped Recovery Pattern
14.3.3 Analysis of Market W-Shaped Recovery Pattern
14.3.4 Analysis of Market U-Shaped Recovery Pattern
14.3.5 Analysis of Market L-Shaped Recovery Pattern
14.4 South Africa Pharmaceutical Contract Manufacturing Market Analysis
14.4.1 Analysis of Market Status Before COVID-19
14.4.2 Analysis of Market V-Shaped Recovery Pattern
14.4.3 Analysis of Market W-Shaped Recovery Pattern
14.4.4 Analysis of Market U-Shaped Recovery Pattern
14.4.5 Analysis of Market L-Shaped Recovery Pattern
14.5 UAE Pharmaceutical Contract Manufacturing Market Analysis
14.5.1 Analysis of Market Status Before COVID-19
14.5.2 Analysis of Market V-Shaped Recovery Pattern
14.5.3 Analysis of Market W-Shaped Recovery Pattern
14.5.4 Analysis of Market U-Shaped Recovery Pattern
14.5.5 Analysis of Market L-Shaped Recovery Pattern
14.6 Egypt Pharmaceutical Contract Manufacturing Market Analysis
14.6.1 Analysis of Market Status Before COVID-19
14.6.2 Analysis of Market V-Shaped Recovery Pattern
14.6.3 Analysis of Market W-Shaped Recovery Pattern
14.6.4 Analysis of Market U-Shaped Recovery Pattern
14.6.5 Analysis of Market L-Shaped Recovery Pattern
14.7 Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis
14.7.1 Analysis of Market Status Before COVID-19
14.7.2 Analysis of Market V-Shaped Recovery Pattern
14.7.3 Analysis of Market W-Shaped Recovery Pattern
14.7.4 Analysis of Market U-Shaped Recovery Pattern
14.7.5 Analysis of Market L-Shaped Recovery Pattern
14.8 Middle East & Africa Market Analysis by Product Category
14.8.1 Analysis of Market Status Before COVID-19
14.8.2 Analysis of Market V-Shaped Recovery Pattern
14.8.3 Analysis of Market W-Shaped Recovery Pattern
14.8.4 Analysis of Market U-Shaped Recovery Pattern
14.8.5 Analysis of Market L-Shaped Recovery Pattern
14.9 Middle East & Africa Market Analysis by Drug Type
14.9.1 Analysis of Market Status Before COVID-19
14.9.2 Analysis of Market V-Shaped Recovery Pattern
14.9.3 Analysis of Market W-Shaped Recovery Pattern
14.9.4 Analysis of Market U-Shaped Recovery Pattern
14.9.5 Analysis of Market L-Shaped Recovery Pattern
14.10 Middle East & Africa Market Analysis by API Contract Manufacturing
14.10.1 Analysis of Market Status Before COVID-19
14.10.2 Analysis of Market V-Shaped Recovery Pattern
14.10.3 Analysis of Market W-Shaped Recovery Pattern
14.10.4 Analysis of Market U-Shaped Recovery Pattern
14.10.5 Analysis of Market L-Shaped Recovery Pattern
14.11 Middle East & Africa Market Analysis by FDF Contract Manufacturing
14.11.1 Analysis of Market Status Before COVID-19
14.11.2 Analysis of Market V-Shaped Recovery Pattern
14.11.3 Analysis of Market W-Shaped Recovery Pattern
14.11.4 Analysis of Market U-Shaped Recovery Pattern
14.11.5 Analysis of Market L-Shaped Recovery Pattern
14.12 Middle East & Africa Market Analysis by End-User
14.12.1 Analysis of Market Status Before COVID-19
14.12.2 Analysis of Market V-Shaped Recovery Pattern
14.12.3 Analysis of Market W-Shaped Recovery Pattern
14.12.4 Analysis of Market U-Shaped Recovery Pattern
14.12.5 Analysis of Market L-Shaped Recovery Pattern
15 Latin America Pharmaceutical Contract Manufacturing Market Analysis
15.1 Latin America Market in Terms of Value
15.1.1 Analysis of Market Status Before COVID-19
15.1.2 Analysis of Market V-Shaped Recovery Pattern
15.1.3 Analysis of Market W-Shaped Recovery Pattern
15.1.4 Analysis of Market U-Shaped Recovery Pattern
15.1.5 Analysis of Market L-Shaped Recovery Pattern
15.2 Brazil Pharmaceutical Contract Manufacturing Market Analysis
15.2.1 Pharmaceutical Manufacturing Regulations in Brazil
15.2.2 Brazil Imports Most of its APIs
15.2.3 Brazil: Pharma Contract Manufacturing Market
15.2.4 Analysis of Market Status Before COVID-19
15.2.5 Analysis of Market V-Shaped Recovery Pattern
15.2.6 Analysis of Market W-Shaped Recovery Pattern
15.2.7 Analysis of Market U-Shaped Recovery Pattern
15.2.8 Analysis of Market L-Shaped Recovery Pattern
15.3 Mexico Pharmaceutical Contract Manufacturing Market Analysis
15.3.1 Mexico: Emerging Market Power
15.3.2 Healthcare – A Top Priority in Mexico
15.3.3 Strategic Management of High Expectations
15.3.4 Mexico: Pharma Contract Manufacturing Market
15.3.5 Analysis of Market Status Before COVID-19
15.3.6 Analysis of Market V-Shaped Recovery Pattern
15.3.7 Analysis of Market W-Shaped Recovery Pattern
15.3.8 Analysis of Market U-Shaped Recovery Pattern
15.3.9 Analysis of Market L-Shaped Recovery Pattern
15.4 Argentina Pharmaceutical Contract Manufacturing Market Analysis
15.4.1 Analysis of Market Status Before COVID-19
15.4.2 Analysis of Market V-Shaped Recovery Pattern
15.4.3 Analysis of Market W-Shaped Recovery Pattern
15.4.4 Analysis of Market U-Shaped Recovery Pattern



★調査レポート[製薬受託製造の世界市場2020-2030] (コード:VGA20DE023)販売に関する免責事項を必ずご確認ください。
★調査レポート[製薬受託製造の世界市場2020-2030]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆